Latest news

BioCryst bets big on rare disease with $700M Astria buyout

BioCryst bets big on rare disease with $700M Astria buyout

Eduardo Longoria
Daily Snap - 14. October 2025

Daily Snap - 14. October 2025

Joachim Eeckhout
Regeneron’s gene therapy restores hearing in children with genetic deafness

Regeneron’s gene therapy restores hearing in children with genetic deafness

Eduardo Longoria
Excellergy raises $70M to reinvent allergy treatment with multi-action drug

Excellergy raises $70M to reinvent allergy treatment with multi-action drug

Eduardo Longoria
Daily Snap - 13. October 2025

Daily Snap - 13. October 2025

Joachim Eeckhout
BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

Eduardo Longoria
Evommune files for IPO to back oral immune drugs for skin conditions

Evommune files for IPO to back oral immune drugs for skin conditions

Eduardo Longoria
Daily Snap - 10. October 2025

Daily Snap - 10. October 2025

Joachim Eeckhout
AviadoBio expands into eye diseases with $413M UgeneX deal

AviadoBio expands into eye diseases with $413M UgeneX deal

Eduardo Longoria
Novo Nordisk buys Akero for $5.2B to lead the MASH drug race

Novo Nordisk buys Akero for $5.2B to lead the MASH drug race

Eduardo Longoria
Daily Snap - 9. October 2025

Daily Snap - 9. October 2025

Joachim Eeckhout
Arthrosi secures $153M series E to fund late-stage gout drug development

Arthrosi secures $153M series E to fund late-stage gout drug development

Eduardo Longoria
FirstBack
89101112131415
Next Last